Targeted Oral Delivery Platform
Treatment at the site of disease in the GI tract could improve outcomes for patients with inflammatory bowel disease
Reimagining therapeutic delivery
We’re innovating smart-pill technologies designed to deliver the right dose to the right place, safely.
Systemic Oral Delivery Platform
Needle-free, oral delivery of large molecules designed to replace injection for better management of chronic diseases.
Press Releases
Publications
Twitter Feed
;
$BIOR to Report Fourth Quarter and Full Year 2022 Financial Results and Provide Corporate Update: https://investors.bioratherapeutics.com/news-releases/news-release-details/biora-therapeutics-report-fourth-quarter-and-full-year-2022 #earningscall
$BIOR has no exposure to and does not bank with Silicon Valley Bank.
$BIOR announces bioavailability results for oral delivery of GLP-1 receptor agonist https://investors.bioratherapeutics.com/news-releases/news-release-details/biora-therapeutics-announces-bioavailability-results-oral #oraldelivery #biologics #needlefree #drugdelivery #semaglutide
Connect with us